Pediatric Innovation Fund

Prize: up to $100,000 
Status: Open

General Guidelines


Children’s National is seeking proposals from inventors who have medical product concepts for use with pediatric patients. Proposals should address a significant, yet unmet need within the pediatric population with a specific innovative “product” and plan for commercialization.

For the purpose of the Pediatric Innovation Fund, we define pediatric medical product as a medical instrument, apparatus, implant, in vitro reagent, methodology, drug, biologic agent or similar or related article that is used to maintain health or diagnose, prevent, or treat disease or other conditions. The Fund administrators also encourage the development of healthcare software and mobile medical apps that improve pediatric health care and provide children, parents, and health care professionals with valuable health information. In sum, all pediatric products (devices, drugs/biologics, diagnostic test, software, etc.) are eligible under this RFP.

The proposal should be directed towards development of a product, not research of a scientific concept. It should define the specific gap/need to be addressed, its quantitative significance (including market, etc.), the competitive landscape, how the proposed product will address the gap, project feasibility, the plan for regulatory approval and commercialization. For devices, issues such as prototyping, manufacturing, marketing, and regulatory clearance will beparamount and should be addressed explicitly. We enthusiastically welcome projects that are past the prototype phase, and are seeking funds to obtain additional product validation that is much required for product commercialization. 

The fund is designated for Children’s National employees or innovators from an external entity that collaborate with Children’s National. If the applicants are working with an external collaborator, the distribution of the external entity/subcontractor cannot exceed 40% of the total budget.

Key Dates 

  • RFP Released – Monday, December 21, 2015
  • Submission of Round 1 deadline – January 22, 2016
  • The judges decide on the selection for Round 2 – First week of February, 2016
  • Notification to Round 2 applicants – First week of February, 2016
  • Live Presentations – First week of March, 2016 
  • Awardees notified – First week of March, 2016 

Review Process and Scoring Criteria 

The written proposal format is listed below.  A subset of submissions will be asked to prepare a 10-minute presentation as noted under Key Dates above. Those notified must be prepared to present live at the final competition. 

Scoring by the judges will be based on an assessment of the following factors: 

  1. Clinical significance of the pediatric product and its innovation 
  2. Product development plan and feasibility
  3. Likelihood of commercialization
  4. Project team, environment, and resources
  5. Potential for additional funding 

This funding is intended to promote the commercialization of a pediatric medical product. The application should include a description of the long term funding strategy and product’s exit strategy. Applicants are encouraged to address how this funding will be used to advance a specific aspect of product development in the overall development plan.   

The success of the Pediatric Innovation Fund will be measured by advancement through the product development progress, generation of intellectual property, clinical trials progress, steps toward FDA approval, follow-on funding, and clinical impact. 

Awardees will be required to submit three quarterly progress reports and a final report. Investigators that do not submit this report will be at risk of losing continued funding support.

Applicants must be up to date with, or able to obtain Institutional Review Board (IRB) or Institutional Animal Care and Use Committee (IACUC) approval for work proposed, if applicable.  Any additional relevant certifications (FWA numbers, CITI certifications, etc.) must be made available upon request.   

Submission and Questions 

Applications should be submitted as a single PDF document through the online system:

Questions about this RFP may be directed to 

Proposal Format 

Proposal Page limit: maximum 6 pages per below guidelines 
Font size: 11 Arial, Margin: 0.5 inches 
Application should include:

Cover page with the following information (1 page): 
  • Title of Project
  • Applicant Name(s), Titles, Email Addresses 
  • Department 
  • Notification email address 
  • Requested Award Amount (must not exceed $100K). Please note that indirect costs are not allowed
  • Abstract – A short executive summary that will be shared with the public (please do not include any confidential information)    

Description of proposed project following the outline provided below (3 pages maximum). The Applications are generally for one year of funding. 

  • Unmet need in pediatric care: Describe the clinical application/situation/condition that the project is to address. Estimates of the number of potential patients that would benefit and describes the intended patient population such as age range, weight, etc. 
  • Product: Describe the pediatric medical product that will be developed with Pediatric Innovation Fund. As appropriate, provide detail on the prototype fabrication, materials, specifications, any software requirements, and method of manufacturing. 
  • Significance: Describe the benefits the project will have on the technologies, treatments, services, or preventative interventions that relate to improvement in pediatric healthcare. 
  • Approach/Milestones: Identify the current state of development of your device (concept, prototype, preclinical, clinical, manufacturing, marketing or commercial use) and describe your approach for moving it through the next few phases with this grant funding for which you are applying. Provide an outlook describing potential sources of funding beyond the Pediatric Innovation Fund. Specify the current status of your intellectual property. Provide your project plan and timeline for commercialization in a Gantt format. 
  • Product Marketing Plans: Describe your market analysis to date. Please include a description of potential competitors and/or competing technologies. 
  • Project Team, Resources and Environment: Describe your project team and the resources you will require to complete the work proposed. Briefly describe any relevant prior experience.

Budget & Budget Justification (1 page): Provide an itemized budget for funds requested. Prototype production, data collection and analysis, clinical and pre-clinical studies, testing, manufacturing costs, cost of consultants, quality systems development, materials, and personnel support are eligible budget categories. The awards are for a maximum of $100,000 for one year.

References (1 page): 

References and citations may be used in support of the description of the proposed project, but should be kept within the page limit. 

Because this is a two-step selection process, applicants are encouraged to work on their presentation should they be selected to present at the final competition.

Presentation Rules and Guidelines 

  • Presentations must be no longer than 5 minutes. Presentations will be hard stopped at the 5-minute mark. Time begins when the presenter begins speaking.
  • You may use visual aids such as slides and videos.
  • There will be a 5-minute Q&A following each presentation.
  • Presenters must be physically present and give the presentation live. No pre-recorded pitches will be allowed. 
  • A list with the presentation order will be generated on the day of the event.
  • The finalists are advised to address the following questions in their presentation. 
    • What is the unmet pediatric medical need? 
    • What is your solution? 
    • Who is the competition? 
    • What makes your solution superior? 
    • What is your business model? 
    • Who is in your team? 
  • Judges will consider the overall presentation including content and delivery.
  • Presenters are encouraged to avoid speaking about topics or items that should remain confidential.